ARK Genomic Revolution ETF Rating $25.28 +1.67 (+7.05%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$25.33 +0.05 (+0.20%) As of 07/11/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.70Holdings in ARKG have an aggregate rating of Moderate Buy based on 388 analyst ratings issued in the past year covering 32 companies (99.8% of the portfolio).ARKG Aggregate Price Target$25.28High Prediction$25.28Average Prediction$25.28Low Prediction$25.28Holdings in ARKG have an aggregate price target of $25.28 and a range of $25.28 to $25.28 covering 32 companies (99.8% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.10%TEMTempus AI$56.88-4.6%2.2836 of 5 stars2.50$65.09 14.4%12Trending NewsInsider Trade9.48%CRSPCRISPR Therapeutics$56.80-3.7%3.2422 of 5 stars2.53$71.75 26.3%17Analyst ForecastOptions Volume7.47%TWSTTwist Bioscience$38.03-1.1%4.3843 of 5 stars2.70$50.40 32.5%10Gap Down6.48%GHGuardant Health$50.25-2.0%4.1158 of 5 stars3.00$53.76 7.0%21Positive News5.67%NTRANatera$160.43-1.8%1.6484 of 5 stars3.00$184.63 15.1%15Positive News5.59%RXRXRecursion Pharmaceuticals$5.28-7.7%2.0021 of 5 stars2.33$7.00 32.6%6Analyst ForecastOptions VolumeGap Down4.37%PSNLPersonalis$6.37-7.9%3.4749 of 5 stars3.00$7.67 20.4%6News Coverage4.21%ADPTAdaptive Biotechnologies$11.82-2.2%2.871 of 5 stars2.86$10.57 -10.6%73.95%SDGRSchrodinger$21.01-3.2%2.3139 of 5 stars2.75$33.25 58.3%43.93%CDNACareDx$20.13-2.4%4.2697 of 5 stars2.67$30.33 50.7%6Positive NewsInsider Trade3.54%TXG10x Genomics$12.80+1.4%4.5103 of 5 stars2.46$14.13 10.4%133.35%IONSIonis Pharmaceuticals$41.73-1.5%4.6661 of 5 stars2.78$58.25 39.6%18Positive News3.25%BEAMBeam Therapeutics$21.16-3.9%2.2592 of 5 stars3.00$48.75 130.4%15News Coverage3.15%VCYTVeracyte$27.08-1.6%3.5901 of 5 stars2.70$40.90 51.0%102.69%NTLAIntellia Therapeutics$11.53-5.2%4.3478 of 5 stars2.65$33.37 189.4%202.65%ABSIAbsci$2.67-2.2%2.3764 of 5 stars3.00$8.40 214.6%52.45%ILMNIllumina$99.25-0.8%4.8682 of 5 stars2.40$125.11 26.1%20Trending NewsAnalyst Forecast2.12%ARCTArcturus Therapeutics$13.78-4.8%1.7393 of 5 stars3.11$54.00 291.9%9Gap Down1.86%NRIXNurix Therapeutics$12.44-1.8%1.5771 of 5 stars2.83$29.59 137.8%18Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.74%MASS908 Devices$6.94-3.9%1.2212 of 5 stars2.50$5.33 -23.2%4Positive News1.56%AMGNAmgen$295.27-1.7%4.4324 of 5 stars2.35$307.82 4.2%23Positive NewsAnalyst Revision1.38%VEEVVeeva Systems$275.82-2.1%3.8949 of 5 stars2.50$271.04 -1.7%24Positive NewsInsider Trade1.32%PACBPacific Biosciences of California$1.47-2.0%1.8382 of 5 stars2.44$2.06 40.2%9News CoverageGap Down1.30%QSIQuantum-Si$1.73-4.4%1.9652 of 5 stars2.67$3.48 100.9%31.30%BFLYButterfly Network$1.81-3.2%2.4985 of 5 stars3.00$3.50 93.4%3Options Volume1.05%VRTXVertex Pharmaceuticals$468.85-2.2%4.3192 of 5 stars2.54$511.62 9.1%28Positive NewsAnalyst Revision1.02%INCYIncyte$68.59-2.5%4.7312 of 5 stars2.22$74.53 8.7%180.92%CERSCerus$1.45-6.5%2.6419 of 5 stars3.00$3.50 141.4%2Positive News0.63%REGNRegeneron Pharmaceuticals$567.74+1.4%4.8285 of 5 stars2.80$814.57 43.5%25Trending NewsAnalyst ForecastAnalyst Revision0.50%PRMEPrime Medicine$4.35-7.2%3.905 of 5 stars2.75$10.08 131.8%8High Trading Volume0.38%LABStandard BioTools$1.32-2.2%3.5957 of 5 stars2.50$2.50 89.4%2Positive News0.38%CMPSCOMPASS Pathways$3.67-1.3%1.8507 of 5 stars2.86$17.00 363.2%7 This page (BATS:ARKG) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
